immunomodulator

(redirected from biologic response modifier)
Also found in: Thesaurus, Medical, Encyclopedia.

immunomodulator

(ˌɪmjʊnəʊˈmɒdjʊˌleɪtə)
n
a substance that affects the functioning of the immune system
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Mentioned in ?
References in periodicals archive ?
In addition to its use in LMs, OK-432's attenuated Streptococcus Pyogenes modality has been approved in Japan as a potent biologic response modifier in adjunctive use with first-line oncology therapies in gastric and lung cancer, and as a direct agent in Thyroid, head and neck tumors and for cancerous pleural effusion and ascites.
My doctor suggested adding a biologic response modifier (BRM) drug, such as etanercept (Enbrel) or adali-mumab (Humira) to my treatment plan, but I've heard that BRMs can increase cancer risk.
If you are taking a biologic response modifier and have an infection severe enough to require antibiotics, the biologic should not be given until the infection is gone.
ATLANTA -- A review of more than 60,000 melanoma patients found they were more likely to have a sentinel node biopsy and receive adjuvant therapy with a biologic response modifier if they had commercial insurance and were treated at a teaching hospital in a geographic area where these options were more often used.
"This is the first use of a biologic response modifier in cystic fibrosis and represents a completely new approach to treatment," stated the study's principal investigator, Richard B.
Tocilizumab (Actemra) is a biologic response modifier that inhibits interleukin-6.
In the past decade, six biologic response modifier (BRM) agents targeting four different biologic targets have been approved by the Food and Drug Administration for the treatment of RA.
ATLANTA -- A review of more than 60,000 melanoma patients found that they were more likely to have a sentinel node biopsy and receive adjuvant therapy with a biologic response modifier if they had commercial insurance and were treated at a teaching hospital in a geographic area where these options were more often used.